Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Genomics Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Genomics Market

5.1. Covid-19: Genomics Industry Impact
5.2. Genomics Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Genomics Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Genomics Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Genomics Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Driver 1
6.1.1.2. Driver 2
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2

Chapter 7. Global Genomics Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Genomics Market Revenue by Market Players
7.1.1.2. Genomics Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Genomics Market, By Product Type

8.1. Genomics Market, by Component, 2023-2032
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Systems and software
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Services Equipment
8.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Genomics Market, By Application

9.1. Genomics Market, by Application, 2023-2032
9.1.1. Sequencing
9.1.1.1. Market Revenue and Forecast 2024-2032
9.1.2. Microarray
9.1.2.1. Market Revenue and Forecast 2024-2032
9.1.3. PCR (polymerase chain reaction)
9.1.3.1. Market Revenue and Forecast 2024-2032
9.1.4. Nucleic acid extraction and purification
9.1.4.1. Market Revenue and Forecast 2024-2032
9.1.5. Others
9.1.5.1. Market Revenue and Forecast 2024-2032

Chapter 10. Global Genomics Market, By End-user

10.1. Genomics Market, by End-user, 2023-2032
10.1.1. Diagnostics
10.1.1.1. Market Revenue and Forecast 2024-2032
10.1.2. Drug discovery and development
10.1.2.1. Market Revenue and Forecast 2024-2032
10.1.3. Precision medicine
10.1.3.1. Market Revenue and Forecast 2024-2032
10.1.4. Agriculture and animal research
10.1.5. Other applications

Chapter 11. Global Genomics Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type2024-2032
11.1.2. Market Revenue Forecast by Application 2024-2032
11.1.3. Market Revenue Forecast by End-user 2024-2032
11.1.4. U.S
11.1.4.1. Market Revenue Forecast 2024-2032
11.1.5. Canada
11.1.5.1. Market Revenue Forecast 2024-2032
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type2024-2032
11.2.2. Market Revenue Forecast by Application 2024-2032
11.2.3. Market Revenue Forecast by End-user 2024-2032
11.2.4. UK
11.2.4.1. Market Revenue Forecast 2024-2032
11.2.5. Germany
11.2.5.1. Market Revenue Forecast 2024-2032
11.2.6. France
11.2.6.1. Market Revenue Forecast 2024-2032
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast 2024-2032
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type2024-2032
11.3.2. Market Revenue Forecast by Application 2024-2032
11.3.3. Market Revenue Forecast by End-user 2024-2032
11.3.4. China
11.3.4.1. Market Revenue Forecast 2024-2032
11.3.5. India
11.3.5.1. Market Revenue Forecast 2024-2032
11.3.6. Japan
11.3.6.1. Market Revenue Forecast 2024-2032
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast 2024-2032
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type2024-2032
11.4.2. Market Revenue Forecast by Application 2024-2032
11.4.3. Market Revenue Forecast by End-user 2024-2032
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast 2024-2032
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast 2024-2032
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type2024-2032
11.5.2. Market Revenue Forecast by Application 2024-2032
11.5.3. Market Revenue Forecast by End-user 2024-2032
11.5.4. GCC
11.5.4.1. Market Revenue Forecast 2024-2032
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast 2024-2032
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast 2024-2032
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast 2024-2032

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin
12.1.4. Recent Developments and Strategies
12.2. Illumina, Inc.
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin
12.2.4. Recent Developments and Strategies
12.3. Oxford Nanopore Technologies
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin
12.3.4. Recent Developments and Strategies
12.4. QIAGEN N.V.
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin
12.4.4. Recent Developments and Strategies
12.5. BGI
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin
12.5.4. Recent Developments and Strategies
12.6. Eurofins Scientific
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin
12.6.4. Recent Developments and Strategies
12.7. GE Healthcare
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin
12.7.4. Recent Developments and Strategies
12.8. Agilent Technologies, Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin
12.8.4. Recent Developments and Strategies
12.9. Bio-Rad Laboratories, Inc.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin
12.9.4. Recent Developments and Strategies
12.10. F. Hoffmann-La Roche Ltd.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms